CHEOY:OTCMKTS
Cochlear Ord ADR
၄၅.၄၄ US$
arrow_upward
+၁.၆၁%(+၀.၇၂) 1D
အောက် ၁၆, GMT-၄ ၁၆:၀၀:၀၀ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CHEOY...
Open
၄၃.၈၄ US$
High
၄၆.၀၄ US$
Low
၄၃.၈၄ US$
Mkt. cap
၈၅၇.၅၈ ဋေ
Avg. vol.
၁.၈၆ သောင်း
Volume
၂.၉၂ သောင်း
52-wk high
၉၈.၄၉ US$
52-wk low
၃၁.၈၂ US$
Beta
၀.၆၈
Shares outstanding
၁၃.၀၈ ကုဋေ
No. of employees
၅ ထောင်
Open
၄၃.၈၄ US$
High
၄၆.၀၄ US$
Low
၄၃.၈၄ US$
Mkt. cap
၈၅၇.၅၈ ဋေ
Avg. vol.
၁.၈၆ သောင်း
Volume
၂.၉၂ သောင်း
52-wk high
၉၈.၄၉ US$
52-wk low
၃၁.၈၂ US$
Beta
၀.၆၈
Shares outstanding
၁၃.၀၈ ကုဋေ
No. of employees
၅ ထောင်
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၁၆ နာရီ
UBS keeps AUD 135.00 target for Cochlear stock
Profile
Cochlear is a medical device company that designs, manufactures, and supplies the Nucleus cochlear implant, the Hybrid electro-acoustic implant and the Baha bone conduction implant.
Based in Sydney, Cochlear was formed in 1981 as a subsidiary of Nucleus with finance from the Australian government to commercialise the implants pioneered by Dr. Graeme Clark, although the company later became separate. As of 2022, the company holds 50% of the cochlear implant market, with more than 250,000 people receiving one of Cochlear's implants as of 2015.
Cochlear was named Australia's most innovative company by the Intellectual Property Research Institute of Australia in 2002 and 2003, and one of the world's most innovative companies by Forbes in 2011. Wikipedia
About Cochlear Ord ADR
CEODig Howitt
Employees၅.၄ ထောင်
Founded၁၉၈၁
Headquartersဆစ်ဒနီ, နယူး ဆောက်သ် ဝေးလ်, ဩစတြေးလျ
Sector-
Websitecochlear.com